Nivaan Care raises $7 M in Series A round led by Sorin Investments

Nivaan Care, a speciality pain management chain, has raised $7 million in a Series A funding round led by Sorin Investments. The round also saw participation from existing investors W Health Ventures, Endiya Partners and Rebright Partners.

Nivaan Care said in a statement that it will use the capital to expand its clinic network across Indian cities, strengthen its clinical and operating infrastructure, and on other activities.

The New Delhi headquartered healthcare startup was founded in 2023 by Nivesh Khandelwal and Vishwas Singh. It had earlier raised $4.25 million in a seed round of funding in February this year.

Nivaan Care operates single-speciality pain management clinics focused on chronic pain, including back, knee, and neck pain. It follows a multidisciplinary care model, combining pain physicians, physiotherapists, and care coordinators to deliver non-surgical and minimally invasive treatments. It operates clinics across Delhi-NCR, Mumbai, Jaipur and Lucknow.

The startup says it has completed over 40,000 consultations and around 5,000 minimally invasive procedures to date.

Nivaan Care Co-founder & CEO Nivesh Khandelwal said, “This capital allows us to scale that model responsibly – by expanding our footprint, deepening clinical capabilities, and continuing to innovate on patient-first pain management solutions that are designed for India’s needs.”

Nivaan Care Co-founder & COO Nivaan Care Vishwas Singh said, “This round enables us to enter new markets such as Bengaluru while building the operational backbone required for expansion into select satellite cities.”

According to the startup, chronic pain affects nearly one in five adults in India but care delivery remains fragmented, oscillating between basic physiotherapy and invasive surgery. Nivaan aims to build an evidence-led middle layer of care that focuses on minimally invasive interventions delivered through a multidisciplinary model.

“What stood out to us is Nivaan’s ability to create a full-stack solution backed by strong clinical acumen, thus giving it a clear first-mover advantage,” said Mandar Dandekar, Partner at Sorin Investments.